Zühlke cooperates with Global Research Platforms on Alzheimer's research

(CONNECT) According to the Schlieren-based software company, the collaboration between Zühlke and Global Research Platforms has "revolutionised Alzheimer's research: it is now faster, safer and more collaborative than ever before". This is to be ensured by a new platform for researchers that enables global cooperation while at the same time protecting sensitive health data. According to the information provided, it also facilitates access: lower entry barriers should democratise access to research data for researchers and students.

The starting point for these efforts was the question of how researchers can gain secure and easy access to the data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) study without jeopardising sensitive patient data. The study had generated a huge data set on pre-symptomatic Alzheimer's disease.

That is why Zühlke is working with Global Research Platforms to develop a platform that enables researchers worldwide to access the same data while maintaining the highest standards of data protection and data security. This is now being optimised based on feedback from the scientific community.

As a second application example, the platform also supports the catalog of the European Network of Neurodegenerative Diseases. This catalog promotes research on neurodegenerative diseases through a comprehensive collection of global studies. By integrating various data sources, this catalog sets new standards in data usage and collaboration. ce/mm